Ted Lee
Lawyers
Filters
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
Meritage Homes $575 million convertible notes offering
The 1.75% convertible senior notes are due 2028
Cohen & Steers $100 million at-the-market offering
The shares are listed on the NYSE
General Motors Financial $2.5 billion senior notes offering
The investment-grade notes are due 2029 and 2034
Pinnacle West Capital stock offering and forward sale agreements
The stock is listed on the NYSE
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Intel $2.55 billion senior notes offering
The senior notes are due 2031, 2034 and 2054
Gates Industrial $246 million secondary offering
The offering involved 20.125 million ordinary shares
Export Development Canada $3.5 billion global bond offering
The investment-grade bonds are due 2029